Comprehensive metabolomic characterization of atrial fibrillation
BackgroundUsing human humoral metabolomic profiling, we can discover the diagnostic biomarkers and pathogenesis of disease. The specific characterization of atrial fibrillation (AF) subtypes with metabolomics may facilitate effective and targeted treatment, especially in early stages.ObjectivesBy in...
Main Authors: | Chengcan Lu, Chunyan Liu, Di Mei, Mengjie Yu, Jian Bai, Xue Bao, Min Wang, Kejia Fu, Xin Yi, Weihong Ge, Jizhong Shen, Yuzhu Peng, Wei Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.911845/full |
Similar Items
-
Metabolomics and Biomarkers for Paroxysmal and Persistent Atrial Fibrillation
by: Li‐Li Zhang, et al.
Published: (2024-02-01) -
Integration of proteomic and metabolomic characterization in atrial fibrillation-induced heart failure
by: Haiyu Zhang, et al.
Published: (2022-12-01) -
Application of plasma metabolome for monitoring the effect of rivaroxaban in patients with nonvalvular atrial fibrillation
by: Mindi Zhao, et al.
Published: (2022-08-01) -
Multicohort Metabolomics Analysis Discloses 9‐Decenoylcarnitine to Be Associated With Incident Atrial Fibrillation
by: Lars Lind, et al.
Published: (2021-01-01) -
Further Advances in Atrial Fibrillation Research: A Metabolomic Perspective
by: Laura Arbeloa-Gómez, et al.
Published: (2022-03-01)